Top

Published in:

01-07-2024 | Systemic Sclerosis | Research Letter

Efficacy and safety of botulinum toxin in treating scleroderma-associated raynaud’s phenomenon: a systematic review and meta-analysis

Authors: Amr Elrosasy, Mohamed Abo Zeid, Shirin cadri, Belal M. Fahmy, Mohamed A. Elzeftawy, Fatma Mohammed, Alaa Ramadan

Published in: Archives of Dermatological Research | Issue 5/2024

Excerpt

To the editor …

Cappelli L, Wigley FM (Aug. 2015) Management of Raynaud Phenomenon and Digital Ulcers in Scleroderma. Rheumatic Disease Clin North Am 41(3):419–438. https://doi.org/10.1016/j.rdc.2015.04.005

Medina S et al (2018) Botulinum toxin type A in the treatment of Raynaud’s phenomenon: A three-year follow-up study, Eur J Rheumatol, vol. 5, no. 4, pp. 224–229, https://doi.org/10.5152/eurjrheum.2018.18013Fiakos G, Kuang Z, Lo E. Improved skin regeneration with acellular fish skin grafts. Engineered Regeneration. 2020;1:95–101. doi:10.1016/j.engreg.2020.09.002

Neumeister MW et al (2009) Botox Therapy for Ischemic Digits, Plast Reconstr Surg, vol. 124, no. 1, pp. 191–201, doi: 10.1097/PRS.0b013e3181a80576.Lima Júnior EM, Moraes Filho MO de, Forte AJ,. Pediatric Burn Treatment Using Tilapia Skin as a Xenograft for Superficial Partial-Thickness Wounds: A Pilot Study. Journal of Burn Care & Research. Published online August 26, 2019. https://doi.org/10.1093/jbcr/irz149

Ennis D, Ahmad Z, Anderson MA, Johnson SR, Botulinum toxin in the management of primary and secondary Raynaud’s phenomenon, (2021) https://doi.org/10.1016/j.berh.2021.101684.W. Du, M. Zhou, C. Zhang, and Q. Sun, The efficacy of botulinum toxin A in the treatment of Raynaud’s phenomenon in systemic sclerosis: A randomized self-controlled trial, Dermatol Ther, vol. 35, no. 7, Jul. 2022, doi: 10.1111/dth.15529

Du W, Zhou M, Zhang C, Sun Q (Jul. 2022) The efficacy of botulinum toxin A in the treatment of Raynaud’s phenomenon in systemic sclerosis: a randomized self-controlled trial. Dermatol Ther 35(7). https://doi.org/10.1111/dth.15529

Bello et al (2017) The therapeutic efficacy of botulinum toxin in treating scleroderma-associated Raynaud’s phenomenon: a randomized, double-blind, placebo-controlled clinical trial. Arthritis Rheumatol 69(8):1661–1669. https://doi.org/10.1002/art.40123

Jokar MH et al (2022) Efficacy of botulinum toxin type A injection for Raynaud's phenomenon and digital ulcers in patients with systemic sclerosis. Reumatologia 60(6):392–398. https://doi.org/10.5114/reum.2022.120757

Senet P et al (2023) Efficacy and safety of botulinum toxin in adults with Raynaud’s phenomenon secondary to systemic sclerosis: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheumatol 75(3):459–467. https://doi.org/10.1002/art.42342

Seyedmardani SM et al (2022) Evaluation of botulinum toxin type A and its potential effect on exacerbated Raynaud’s phenomenon in hospitalized scleroderma patients. Curr Rheumatol Rev 18(1):48–57. https://doi.org/10.2174/1573397117666211012105611

Title: Efficacy and safety of botulinum toxin in treating scleroderma-associated raynaud’s phenomenon: a systematic review and meta-analysis
Authors: Amr Elrosasy
Mohamed Abo Zeid
Shirin cadri
Belal M. Fahmy
Mohamed A. Elzeftawy
Fatma Mohammed
Alaa Ramadan
Publication date: 01-07-2024
Publisher: Springer Berlin Heidelberg
Keywords: Systemic Sclerosis
Scleroderma
Botulinum Toxin
Phosphodiesterase-5 Inhibitor
Published in: Archives of Dermatological Research / Issue 5/2024
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI: https://doi.org/10.1007/s00403-024-02864-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Efficacy and safety of botulinum toxin in treating scleroderma-associated raynaud’s phenomenon: a systematic review and meta-analysis

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2024

Cutaneous inflammasome driving ASC / gasdermin-D activation and IL-1β-secreting macrophages in severe atopic dermatitis

Understanding patient perspectives on vaccine decision making in adults with autoimmune bullous diseases: a qualitative study

Antibiotic adherence in dermatologic surgery: a Multicenter prospective cohort study

Evaluation of cardiac function in patients with pemphigus vulgaris before and after rituximab infusion

The relationship between spiritual practices and psychological well-being in chronic skin diseases

Malignant melanoma arising in a burn scar